Boehringer Ingelheim
Katye Gemma, J.D., MBA, currently serves as Director and Senior Counsel II - Market Access at Boehringer Ingelheim, a position held since December 2021. Prior experience includes roles such as Managing Director at Principle Wealth Partners, where responsibilities included business operations, process improvement, and cross-functional leadership, and Senior Director of Contracts and Pricing at Acer Therapeutics Inc., focusing on pricing strategies for ultra-high-cost medications. Katye also accumulated extensive experience at Rhodes Pharmaceuticals as Director & Legal Counsel for Commercial Sales and Operations, and previously worked as an attorney in both private practice and public service, including the Rhode Island Ethics Commission and the City of Providence. Academic credentials include a Juris Doctor from Roger Williams University School of Law, an MBA in Health Care Delivery Systems from the University of Phoenix, and a BA in Political Science/Business Administration from King's College.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.